PANEL | Evolving paradigms in mental health care and funding
PANEL | Evolving paradigms in mental health care and funding


Justin James joined HIF in mid 2020, bringing with him a wealth of experience in senior executive positions across Health Insurance and Financial Services, most recently with Private Health Insurer Bupa. In his eight years as Director of Customer Growth and Director of Risk & Conduct with Bupa, Justin pioneered an ethical approach to performance and remuneration. Before moving into the Private Health Insurance industry, Justin held several senior executive and leadership roles in the Financial Services sector, including at the National Australia Bank, Commonwealth Bank and ANZ Bank. On his arrival at HIF Justin set about renewing confidence across the HIF community and improving the value HIF members receive from their cover with a keen focus on access and choice. Justin and HIF are keen supporters into studies relating to the health benefits of medicinal cannabis and other emerging therapies targeting mental health treatments. In addition to being CEO of HIF, Justin is Chair of Allevia, an NDIS services provider and a NED with the AMA (WA).

Rav joined Healthe Care in 2021 having held senior roles in hospital and provider contracting for a number of health insurers including HBF and Medibank. An experienced negotiator and relationship manager, he has a passion for working with hospitals to develop new models of care that work for patients, hospitals and funders. Prior to working in private healthcare he worked in roles across Governance, Policy Development, Procurement and Risk Management in a variety of sectors such as IT, Superannuation and Government. Rav has a Bachelor of Laws and is a non-practicing Barrister (England and Wales).

Dr Kerryn Rubin is the Clinical Director of Mental Health at Peninsula Health, an Adjunct Senior Lecturer at Monash University, and is the immediate past Chair of the Royal Australian and New Zealand College of Psychiatry’s Victorian Branch Committee. Kerryn has over 2 decades of experience in public and private mental health services. His areas of expertise include general adult psychiatry, psychotherapy, and Trauma work. Kerryn has clinical and academic expertise in Supported Decision Making, recovery oriented services, co-production, and Trauma Informed Care. Kerryn is a passionate advocate for reducing the use of Treatment Orders, and the reduction of restrictive interventions, whilst maintaining safe and therapeutic hospital environments. In his time as Clinical Director at PH they have built on their already advanced work in reducing restrictive interventions, and have essentially eliminated the use of seclusion in their service.

Professor Newton is an Adjunct Clinical Professor at Monash University, recent past Clinical Director of the Peninsula Health Mental Health Service. He is on the Boards of Wellways, Mental Health Victoria, and the World Association of Psychosocial Rehabilitation (Australian Branch).
He helped establish the Homeless Outreach Psychiatric Services across Melbourne, established the BETRS Day Patient Program for those with severe eating disorders, and has led the reduction of restrictive practices across a number of health services.
In 2021 Richard was awarded the RANZCP College Citation for his contributions to psychiatry in Australia. In 2009 Professor Newton received the RANZCP’s Margaret Tobin Award, which acknowledged his valuable contributions to administrative psychiatry, and these have continued in the decade since. He is strongly committed to quality and safety systems in mental health, and the provision of safe, effective, evidence-based interventions for all members of the community.
Professor Newton has published over 75 peer-reviewed articles or book chapters and co-wrote the RANZCP clinical practice guidelines for the treatment of eating disorders
• How to secure adequate funding to meet growing demand for services and innovative model of care? • Are there opportunities for collaboration between public and private sectors? Any learnings from the two? • Are there funding priorities within the clinical model of care? • Any examples of successful innovative funding strategies or partnerships?